44 related articles for article (PubMed ID: 29762173)
1. Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity.
Laumaea A; Marchitto L; Ding S; Beaudoin-Bussières G; Prévost J; Gasser R; Chatterjee D; Gendron-Lepage G; Medjahed H; Chen HC; Smith AB; Ding H; Kappes JC; Hahn BH; Kirchhoff F; Richard J; Duerr R; Finzi A
Cell Rep; 2023 Jan; 42(1):111983. PubMed ID: 36640355
[TBL] [Abstract][Full Text] [Related]
2. A defucosylated anti-CD317 antibody exhibited enhanced antibody-dependent cellular cytotoxicity against primary myeloma cells in the presence of effectors from patients.
Ishiguro T; Kawai S; Habu K; Sugimoto M; Shiraiwa H; Iijima S; Ozaki S; Matsumoto T; Yamada-Okabe H
Cancer Sci; 2010 Oct; 101(10):2227-33. PubMed ID: 20701608
[TBL] [Abstract][Full Text] [Related]
3. Integrated proteomics and transcriptomics analyses identify novel cell surface markers of HIV latency.
Beliakova-Bethell N; Manousopoulou A; Deshmukh S; Mukim A; Richman DD; Garbis SD; Spina CA
Virology; 2022 Aug; 573():50-58. PubMed ID: 35714458
[TBL] [Abstract][Full Text] [Related]
4. Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
Grenier MC; Ding S; Vézina D; Chapleau JP; Tolbert WD; Sherburn R; Schön A; Somisetti S; Abrams CF; Pazgier M; Finzi A; Smith AB
ACS Med Chem Lett; 2020 Mar; 11(3):371-378. PubMed ID: 32184972
[TBL] [Abstract][Full Text] [Related]
5. Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
Li W; Chen C; Drelich A; Martinez DR; Gralinski LE; Sun Z; Schäfer A; Kulkarni SS; Liu X; Leist SR; Zhelev DV; Zhang L; Kim YJ; Peterson EC; Conard A; Mellors JW; Tseng CK; Falzarano D; Baric RS; Dimitrov DS
Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29832-29838. PubMed ID: 33139569
[TBL] [Abstract][Full Text] [Related]
6. Associations between NK Cells in Different Immune Organs and Cellular SIV DNA and RNA in Regional HLADR
Li X; Zhu L; Yin Y; Fan X; Lv L; Zhang Y; Pan Y; Yan Y; Liang H; Xue J; Shen T
Viruses; 2022 Nov; 14(11):. PubMed ID: 36423122
[TBL] [Abstract][Full Text] [Related]
7. Neutralization Sensitivity of HIV-1 CRF07_BC From an Untreated Patient With a Focus on Evolution Over Time.
Wang L; Liang S; Huang J; Ding Y; He L; Hao Y; Ren L; Zhu M; Feng Y; Rashid A; Liu Y; Jiang S; Hong K; Ma L
Front Cell Infect Microbiol; 2022; 12():862754. PubMed ID: 35372102
[TBL] [Abstract][Full Text] [Related]
8. Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir.
Suryawanshi P; Bagul R; Shete A; Thakar M
Front Immunol; 2021; 12():663919. PubMed ID: 33995393
[TBL] [Abstract][Full Text] [Related]
9. Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV.
Wang L; Xu J; Kong Y; Liang R; Li W; Li J; Lu J; Dimitrov DS; Yu F; Wu Y; Ying T
Antibodies (Basel); 2019 Nov; 8(4):. PubMed ID: 31690009
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles expressing a single-chain variable fragment of an HIV-1 specific antibody selectively target Env
Zou X; Yuan M; Zhang T; Wei H; Xu S; Jiang N; Zheng N; Wu Z
Theranostics; 2019; 9(19):5657-5671. PubMed ID: 31534509
[No Abstract] [Full Text] [Related]
11. Deficient IL-2 Produced by Activated CD56
Xie Z; Zheng J; Wang Y; Li D; Maermaer T; Li Y; Tu J; Xu Q; Liang H; Cai W; Shen T
Front Immunol; 2019; 10():1647. PubMed ID: 31379845
[No Abstract] [Full Text] [Related]
12. Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus Infection.
Wu Y; Xue J; Wang C; Li W; Wang L; Chen W; Prabakaran P; Kong D; Jin Y; Hu D; Wang Y; Lei C; Yu D; Tu C; Bardhi A; Sidorov I; Ma L; Goldstein H; Qin C; Lu L; Jiang S; Dimitrov DS; Ying T
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375583
[TBL] [Abstract][Full Text] [Related]
13. Potent
Bardhi A; Wu Y; Chen W; Li W; Zhu Z; Zheng JH; Wong H; Jeng E; Jones J; Ochsenbauer C; Kappes JC; Dimitrov DS; Ying T; Goldstein H
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794022
[TBL] [Abstract][Full Text] [Related]
14. Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.
Lee WS; Richard J; Lichtfuss M; Smith AB; Park J; Courter JR; Melillo BN; Sodroski JG; Kaufmann DE; Finzi A; Parsons MS; Kent SJ
J Virol; 2016 Feb; 90(4):2021-30. PubMed ID: 26656700
[TBL] [Abstract][Full Text] [Related]
15. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
16. Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization?
Lee WS; Kent SJ
Curr Opin HIV AIDS; 2018 Mar; 13(2):160-166. PubMed ID: 29194123
[TBL] [Abstract][Full Text] [Related]
17. Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection.
Ferrari G; Pollara J; Tomaras GD; Haynes BF
J Infect Dis; 2017 Mar; 215(suppl_3):S152-S159. PubMed ID: 28520963
[TBL] [Abstract][Full Text] [Related]
18. A defucosylated bispecific multivalent molecule exhibits broad HIV-1-neutralizing activity and enhanced antibody-dependent cellular cytotoxicity against reactivated HIV-1 latently infected cells.
Kong D; Wang Y; Ji P; Li W; Ying T; Huang J; Wang C; Wu Y; Wang Y; Chen W; Hao Y; Hong K; Shao Y; Dimitrov DS; Jiang S; Ma L
AIDS; 2018 Aug; 32(13):1749-1761. PubMed ID: 29762173
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
